Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma HELP
Based on 37,087 articles published since 2010
|||| 18 

These are the 37087 published articles about Melanoma that originated from Worldwide during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
376 Editorial DNp73: oncotarget in invasion and metastasis. 2014

Pützer, Brigitte M. ·Institure of Experimental Gene Therapy and Cancer Research, Rostock University Medical Center, Rostock, Germany. ·Oncotarget · Pubmed #24398448.

ABSTRACT: -- No abstract --

377 Editorial Plasticity of melanoma and EMT-TF reprogramming. 2014

Tulchinsky, Eugene / Pringle, J Howard / Caramel, Julie / Ansieau, Stéphane. ·Department of Cancer Studies and Molecular Medicine, University of Leicester, RKCSB, LRI, Leicester, UK. ·Oncotarget · Pubmed #24369126.

ABSTRACT: -- No abstract --

378 Editorial Melanoma in mankind's best friend. 2014

Bosenberg, Marcus / Arnheiter, Heinz / Kelsh, Robert. · ·Pigment Cell Melanoma Res · Pubmed #24344626.

ABSTRACT: -- No abstract --

379 Editorial Adjuvant interferon in melanoma: is duration of therapy important? 2014

McArthur, Grant A. ·Peter MacCallum Cancer Centre, East Melbourne; University of Melbourne, Parkville, Victoria, Australia. ·J Clin Oncol · Pubmed #24344216.

ABSTRACT: -- No abstract --

380 Editorial Melanoma in childhood: changing our mind-set. 2013

Silverberg, Nanette B / McCuaig, Catherine C. ·Department of Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Ste 11D, New York, NY 10025, USA. nsilverb@chpnet.org. ·Cutis · Pubmed #24343205.

ABSTRACT: -- No abstract --

381 Editorial [BRAF: the pathologist's favorite oncogene]. 2013

Sabourin, Jean-Christophe. ·Service de pathologie, pôle de biologie clinique, pathologie, physiologie, CHU de Rouen, 1, rue de Germont, 76000 Rouen, France. Electronic address: jean-christophe.sabourin@chu-rouen.fr. ·Ann Pathol · Pubmed #24331718.

ABSTRACT: -- No abstract --

382 Editorial Guidelines of care for the management of primary cutaneous melanoma. 2013

Johnson, Timothy M. ·Departments of Dermatology, Otolaryngology, and Surgery (Division of Plastic Surgery), University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan. Electronic address: timjohn@med.umich.edu. ·J Am Acad Dermatol · Pubmed #24238159.

ABSTRACT: -- No abstract --

383 Editorial Bortezomib: a therapeutic resource for the veterinary oncologist? 2013

Reisman, Scott A. ·Reata Pharmaceuticals, 2801 Gateway Dr. Ste 150, Irving, TX 75063, USA. Electronic address: scott.reisman@reatapharma.com. ·Vet J · Pubmed #24210275.

ABSTRACT: -- No abstract --

384 Editorial Who should be offered a sentinel node biopsy for melanoma less than 1 mm in thickness? 2013

Goydos, James S. ·Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway; Cancer Institute of New Jersey, New Brunswick, NJ. ·J Clin Oncol · Pubmed #24190121.

ABSTRACT: -- No abstract --

385 Editorial Does our "flight and fight" response have a link with cancer? 2013

Kohli, Manish. ·Department of Oncology, Mayo Clinic, Rochester, MN. Electronic address: kohli.manish@mayo.edu. ·Mayo Clin Proc · Pubmed #24182698.

ABSTRACT: -- No abstract --

386 Editorial Ophthalmic oncology in Nepal - an area requiring special attention. 2013

Badhu, B P. ·BP Koirala Institute of Health Sciences, Dharan, Nepal. ·Nepal J Ophthalmol · Pubmed #24172546.

ABSTRACT: -- No abstract --

387 Editorial Molecular biomarkers of prognosis in melanoma: how far are we from the clinic? 2013

Schramm, Sarah-Jane / Menzies, Alexander M / Mann, Graham J. ·aThe University of Sydney at Westmead Millennium Institute for Medical Research bMelanoma Institute Australia, Sydney, New South Wales, Australia. ·Melanoma Res · Pubmed #24165033.

ABSTRACT: -- No abstract --

388 Editorial Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic? 2013

Luke, Jason John / Ott, Patrick Alexander. ·Dana-Farber Cancer Institute, Harvard Medical School, Melanoma Disease Center, Early Drug Development Center, Center for Immuno Oncology , 450 Brookline Ave, Boston, MA 02215 , USA +1 6176324715 ; +1 6176326727 ; Jason_luke@dfci.harvard.edu. ·Expert Opin Pharmacother · Pubmed #24138302.

ABSTRACT: In recent years, therapeutic approaches for many tumors have broadened or even shifted entirely from cytotoxic chemotherapy to specific targeting of dysregulated proteins (predominately kinases), and more recently, harnessing of the anti-tumor immune response. The most prominent example of this shift is the management of metastatic melanoma, where BRAF and MEK inhibition and CLTA-4 blockade have established an entirely new standard of care in the last 3 years. Targeted kinase inhibition and immune checkpoint blockade have different strengths and weaknesses. Kinase inhibitors generally have rapid and impressive response rates but modest progression-free survival while immunotherapy can achieve durable tumor control, but is often associated with lower response rates and slower time to clinical benefit. These approaches would seem to be complementary however the results of early combination studies suggest that caution is advised when combining targeted kinase inhibition with immunotherapy. In this context, rigorous biomarker driven clinical trials are needed to further elucidate mechanisms of both benefit and toxicity. Depending on disease specific biology, it seems likely that both combination and sequential approaches of kinase inhibitors with immunotherapy will be required in order to harness the full potential of these approaches.

389 Editorial A sea change in melanoma. 2013

Bates, Susan E. · ·Clin Cancer Res · Pubmed #24089440.

ABSTRACT: -- No abstract --

390 Editorial Recent advances in the treatment of melanoma. 2013

Zager, Jonathan S / Sarnaik, Amod A / Gibney, Geoffrey T / Kudchadkar, Ragini R. ·Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. Jonathan.Zager@Moffitt.org. ·Cancer Control · Pubmed #24077400.

ABSTRACT: -- No abstract --

391 Editorial Acral melanoma: a unique disease in Asia. 2013

Chang, John Wen-Cheng. ·Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. ·JAMA Dermatol · Pubmed #24068331.

ABSTRACT: -- No abstract --

392 Editorial On the cusp of a revolution: melanoma molecular diagnostics. 2013

Carlson, John Andrew. ·Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, New York. Electronic address: carlsoa@mail.amc.edu. ·J Am Acad Dermatol · Pubmed #24034371.

ABSTRACT: -- No abstract --

393 Editorial Is pediatric melanoma always malignant? 2013

Coit, Daniel G / Ernstoff, Marc S / Busam, Klaus J. ·Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. ·Cancer · Pubmed #24022827.

ABSTRACT: -- No abstract --

394 Editorial Malignant melanoma and epidermolysis bullosa simplex. 2013

Fine, Jo-David. ·Departments of Medicine (Dermatology) and Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. ·JAMA Dermatol · Pubmed #23966137.

ABSTRACT: -- No abstract --

395 Editorial Sunbeds and young people: an easy target for legislation? 2013

Diffey, B. · ·Br J Dermatol · Pubmed #23941246.

ABSTRACT: -- No abstract --

396 Editorial Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands. 2013

McGregor, J M. · ·Br J Dermatol · Pubmed #23941245.

ABSTRACT: -- No abstract --

397 Editorial Another option in our KIT of effective therapies for advanced melanoma. 2013

Carvajal, Richard D. ·Memorial Sloan-Kettering Cancer Center, New York, NY. ·J Clin Oncol · Pubmed #23940226.

ABSTRACT: -- No abstract --

398 Editorial Improving apoptotic responses to targeted therapy. 2013

Haq, Rizwan / Fisher, David E. ·Department of Dermatology, Massachusetts General Hospital. ·Oncotarget · Pubmed #23934756.

ABSTRACT: -- No abstract --

399 Editorial Radiation lays down covering fire for viral shock troops. 2013

Kyula, Joan N / Khan, Aadil A / Wilkinson, Michelle J / Mansfield, David / Harrington, Kevin J. ·Department of cancer biology, Institute of Cancer Research, London. ·Oncotarget · Pubmed #23912566.

ABSTRACT: -- No abstract --

400 Editorial Levels of evidence in canine oncology trials--a case in point. 2013

Vail, David M. · ·Vet Comp Oncol · Pubmed #23909995.

ABSTRACT: -- No abstract --

Back · Next